Key result
Pulmonary artery catheter guidance fails to prevent worsening renal function compared to clinical assessment alone.
Why the study?
Baseline renal insufficiency and worsening renal function during treatment of decompensated heart failure are associated with adverse outcomes, but their impact and pathophysiology require further understanding.
Does pulmonary artery catheter guidance prevent worsening renal function or improve outcomes compared to clinical assessment alone in patients hospitalized with advanced decompensated heart failure?
Population
Patients hospitalized with advanced decompensated heart failure from the ESCAPE database
Comparison
Pulmonary artery catheter guidance vs clinical assessment alone
Design
Randomized controlled trial
Follow-up
6 months
Authors
Loading...
Should not yet change practice toward PAC-guided care to prevent WRF in HF; leaves open alternative explanations for cardiorenal interactions.**[[1]](https://pubmed.ncbi.nlm.nih.gov/18371557/)[[2]](https://www.sciencedirect.
RCT
randomized
Does pulmonary artery catheter guidance prevent worsening renal function or improve outcomes compared to clinical assessment alone in patients hospitalized with advanced decompensated heart failure?
In patients with advanced decompensated heart failure, baseline renal insufficiency is a stronger predictor of adverse outcomes than worsening renal function, and PAC-guided therapy does not prevent worsening renal function.
Nohria et al. (2008) conducted an RCT in Advanced decompensated heart failure. Pulmonary artery catheter (PAC) guidance vs. Clinical assessment alone was evaluated on Death and death or rehospitalization at 6 months. In patients with advanced decompensated HF, right atrial pressure correlated weakly with baseline serum creatinine (r=0.165, p=0.03), and PAC guidance did not prevent worsening renal function.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: